2 ms·
I think we are in agreement, but you did say "2. Evolved resistance with an entirely new set of mutations”. I was pointing out that evolution is not coming abou
by danieltillett 11y ago
I think we are in agreement, but you did say "2. Evolved resistance with an entirely new set of mutations”. I was pointing out that evolution is not coming about from the selection of new mutations, but the selection of pre-existing mutations present with the tumour before treatment.
>Drugging all of these targets in advance is impossible - we can barely drug one gene with patients tolerating it. We'll lose this game of whack-a-mole.
It is not impossible, just difficult. It will certainly be impossible if we keep trying to develop new treatments the way we have for the last 50 years. We need to change the entire way we screen and test new cancer treatments if we are going to be able to use the HAART approach in human cancer.
I agree with you that immunotherapy is looking the most promising approach right now, but done right chemotherapy has a lot of potential too. I would not rule one or the other out.